𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetic and pharmacodynamic study of IST-622, a novel synthetic derivative of chartreusin, by oral administration in a phase II study of patients with breast cancer

✍ Scribed by Gyo Asai; Nobuyuki Yamamoto; Masakazu Toi; Eisei Shin; Kiyoshi Nishiyama; Tomohisa Sekine; Yasuo Nomura; Shigemitsu Takashima; Morihiko Kimura; Takeshi Tominaga

Publisher
Springer
Year
2002
Tongue
English
Weight
123 KB
Volume
49
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II and pharmacodynamic study of
A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer
✍ Edwin M. Posadas; Meghan S. Liel; Virginia Kwitkowski; Lori Minasian; Andrew K. πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 145 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The primary objective of this study was to evaluate the biochemical effects of gefitinib on its target signal‐transduction pathways in patients with recurrent epithelial ovarian cancer (EOC). The secondary objectives included assessing clinical activity and toxicity and d

Clinical activity of cisplatin and prolo
Clinical activity of cisplatin and prolonged oral administration of etoposide in previously treated, anthracycline-resistant, metastatic breast cancer patients: A phase II study
✍ Fried, Getta; Stein, Moshe E.; Haim, Nissim πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 62 KB πŸ‘ 2 views

Background. This phase II study evaluates the antitumor activity and tolerance of cisplatin and prolonged oral administration of etoposide in metastatic breast cancer previously exposed to anthracyclines. Procedure. Twenty-seven patients with metastatic breast cancer who developed tumor progression